Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human CAPS1 ELISA Kit (AC3202)
Cat.#: ASET-1791
Specifications
Description Human CAPS1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CAPS1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 6.94 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2388 Rabbit CRH ELISA Kit (AC3799) Quantitative inquiry ASET-2210 Monkey TIMP1 ELISA Kit (AC3621) Quantitative inquiry ASET-1148 Human Contactin 1 ELISA Kit (AC2559) Quantitative inquiry ASET-1782 Mouse Dopamine Transporter ELISA Kit (AC3193) Quantitative inquiry ASET-1348 Human Luteinizing Hormone ELISA Kit (AC2759) Quantitative inquiry ASET-2128 Human Chromogranin A ELISA Kit (AC3539) Quantitative inquiry ASET-2002 Human 160 kD Neurofilament Medium ELISA Kit (AC3413) Quantitative inquiry ASET-1065 Mouse Visfatin ELISA Kit (AC2476) Quantitative inquiry ASET-1770 Rat AVPR1B ELISA Kit (AC3181) Quantitative inquiry ASET-1479 Human IL-6 ELISA Kit (AC2890) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket